Our Labs
Quick Facts
10 Principal Investigators
$18M active grants, incl. $10M from NIH
7 Endowed professorships
7 Research labs
5 Active VA Merit Rev. Awards
Contact
Megan Maguire
Basic Research Admin.
Dept. of Dermatology
mmaguire@dermatology.wisc.edu
608-261-1878
About our labs
Basic research faculty in the Department of Dermatology study a wide range of dermatological disorders, including skin cancers and non-cancer skin diseases such as Psoriasis, depigmentation, and skin discoloration.
Research targets in our labs range from cellular mechanisms of disease progression and drug resistance to patient presentation in a clinical setting, and our researchers are investigating new uses for current drugs such as anti-inflammatories, as well as the use of plant-based chemicals for chemoprevention.
Our world-renowned researchers are supported by grants from the Dermatology Foundation, the National Institutes of Health, the Department of Veterans Affairs, the Department of Defense and several other non-profit organizations and companies.
Research Topics by Lab
This is an accordion element with a series of buttons that open and close related content panels.
All Labs
- Melanoma development and progression
- Use of plant-based chemicals for chemoprevention
- Role of Plk1 in Cancer
- Role of SIRT1 in Cancer
- Chemoprevention of Cancer by Resveratrol
- Frizzled6 signaling in hair orientation control
- Astrotactin2 in PCP and development
- Melanoma development and progression
- Blastic plasmacytoid dendritic cell neoplasm
- Depigmentation
- Skin discoloration
- Establishing mastocytosis as an oncogene driven neoplasia
- Discovery and characterization of the intracellular-juxtamembrane class of KIT activating mutations
- Discovery of human epidermal keratinocyte KIT ligand and creation of humanized K14-KIT ligand transgenic mice with epidermal melanocytes
- Melanoma development and progression
- Psoriasis
- New uses for existing anti-inflammatories
- Use of plant-based chemicals for chemoprevention
- Cancer prevention and therapy
- Prevention of photocarcinogenesis and photoaging
- Apoptosis by dietary factors: the suicide solution for delaying cancer growth
- Nanochemoprevention-sustained release of bioactive food components for cancer prevention
- Cancer biomarkers
- Cutaneous T-cell lymphomas
- Cellular mechanisms of disease progression and drug resistance
- Phenotypic plasticity and drug-resistance
- Metabolic dynamics during cancer progression
- Targeting the mitochondrial stress response
- Melanoma development and progression
- Cellular mechanisms of disease progression and drug resistance
- Melanocyte biology
- Melanoma development and progression
- Patient presentation in a clinical setting
Labs by Research Topic
This is an accordion element with a series of buttons that open and close related content panels.
Labs by Topic: Skin Cancer
Labs by Topic: Non-Cancer Skin Diseases
Labs by Topic: Research Target
Research News
Gary S. Wood, MD, Recognized for a Career of Academic Accomplishments
In recognition of his academic accomplishments during 18 years of service to the university, Dr. Gary S. Wood (the Founding Chair of the Department of Dermatology) has received two recent honors. First, Dr. Beth Drolet …
July 3, 2019Chang Wins Stiefel Research Award
Assistant Professor of Dermatology Hao Chang, PhD, received the 2019 Daneen & Charles Stiefel Investigative Scientist Award for Melanoma Research from the American Skin Association. The $100,000, one-year award will support Chang’s research on the …
January 3, 2019UWSDRC Funds Six Pilot Awards In 2019
After a successful application cycle, the UW Skin Disease Research Center announces funding of six new pilot projects totaling almost $200,000. We are pleased to fund several applications with direct clinical relevance in this cycle, …
October 15, 2018- More Research News posts
Recent Publications
See what we're publishing! Our clinical and research faculty and their staff publish their research in a variety of top-tier journals.
Active Research Grants
See what we're working on! We receive funding from federal, state, and private sources.
